This inventor holds 4 USPTO granted patents. Top assignee: S.l.a. Pharma Ag. Active years: 2003-2012.
Location History:
- Northwood, GB (2003 - 2011)
- Middlesex, GB (2012)
Company Filing History:
Years Active: 2003-2012
Title: Innovations by Robin K S Phillips
Introduction
Robin K S Phillips is a notable inventor based in Northwood, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of anorectal disorders. With a total of four patents to his name, Phillips has focused on developing topical pharmaceutical compositions that utilize cholinergic agents and calcium channel blockers.
Latest Patents
Phillips' latest patents include a topical pharmaceutical composition that comprises a cholinergic agent or a calcium channel blocker. This innovative method is designed for the treatment of anorectal disorders and aims to control the pain associated with such conditions. The method involves administering therapeutically effective amounts of a calcium channel blocker, either alone or in combination with a nitric oxide donor. Suitable calcium channel blockers mentioned in his patents include amlodipine, diltiazem, and nifedipine, among others. Additionally, he has developed a composition that administers agents like bethanechol and diltiazem locally to the anus for treating benign anal disorders, particularly anal fissures and hemorrhoids. These agents work by reducing mean and resting pressure, thereby assisting in the healing process.
Career Highlights
Phillips has established himself as a key figure in the pharmaceutical industry through his innovative work. His patents reflect a deep understanding of the mechanisms involved in treating anorectal disorders, showcasing his commitment to improving patient care.
Collaborations
Phillips collaborates with Michael A Kamm, contributing to the advancement of pharmaceutical innovations.
Conclusion
Robin K S Phillips is a distinguished inventor whose work in developing topical pharmaceutical compositions has the potential to significantly impact the treatment of anorectal disorders. His innovative approaches and collaborations continue to pave the way for advancements in the pharmaceutical field.